1Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999,340:l15-126.
2Ridker PM, Rifai N, Pteffer MA, et al. Braunwald E. Longterm effects of pravastatin on plasma concentration of C-re-aetive protein. The Cholesterol and Reeurrent Events(CARE) Investigators[J]. Circulation, 1999,100:230-235.
3Biasucci LM,Liuzzo G,Girllo RL, et al . Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability[J]. Circulantion, 1999,99 :855-860.
4Heller A,Koch T,Schmeck J, et al . Lipid mediators in inflammatory disorders[J]. Drugs, 1998,55:487-496.
5Abdelmouttaleb I, Danchin N, Ilardo C, et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes[J]. Am Heart J, 1999,137:346-351.
6Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs [J]. Circulaticon,1999,.99:2452-2457.
7Endres S, Lorenz R, Loesehke K. Lipid treatment of inflammatory bowl disease[J]. Curr Opin Clin Nutr Metab Care,1999,2 : 117-120.
8Christensen JH, Christensen MS, Dyerberg J, et al. Heart rate variability and fatty acid content of blood cell membranes:a dose-response study with n-3 fatty acids[J]. Am J Clin Nutr, 1999,70 : 331-337.
9Simopoulos AP. Essential fatty acids in health and chronic disease[J]. Am J Clin Nutr, 1999,70(suppl. ): 560S-569S.
10De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation[J]. Am J Clin Nutr, 2000, 71(suppl. ) :213S-223S.
同被引文献10
1安邦权,王凤学.血液学检验标准操作程序[M].贵阳:贵州科技出版社,2007:287-293.
2安邦权;王凤学.血液学检验标准操作程序[M]贵阳:贵州科学技术出版社,2007287-293.
3Mohammed A,Melhrabani PA,Coombs R. The MDA-180coagulation analyzer:a laboratory evaluation[J].Pathology,1997.176-183.
4U.S department of health and human services. Medicare,Medicaid and CLIA program:regulations implementing the clinical laboratory improvement amendments of 1988 (CLIA).Final rules[J].The Federal Register,1992.7002-7186.
